Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- PMID: 20829306
- DOI: 10.1177/0269881110379283
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
Abstract
Animal and human studies indicate that cannabidiol (CBD), a major constituent of cannabis, has anxiolytic properties. However, no study to date has investigated the effects of this compound on human pathological anxiety and its underlying brain mechanisms. The aim of the present study was to investigate this in patients with generalized social anxiety disorder (SAD) using functional neuroimaging. Regional cerebral blood flow (rCBF) at rest was measured twice using (99m)Tc-ECD SPECT in 10 treatment-naïve patients with SAD. In the first session, subjects were given an oral dose of CBD (400 mg) or placebo, in a double-blind procedure. In the second session, the same procedure was performed using the drug that had not been administered in the previous session. Within-subject between-condition rCBF comparisons were performed using statistical parametric mapping. Relative to placebo, CBD was associated with significantly decreased subjective anxiety (p < 0.001), reduced ECD uptake in the left parahippocampal gyrus, hippocampus, and inferior temporal gyrus (p < 0.001, uncorrected), and increased ECD uptake in the right posterior cingulate gyrus (p < 0.001, uncorrected). These results suggest that CBD reduces anxiety in SAD and that this is related to its effects on activity in limbic and paralimbic brain areas.
Similar articles
-
Effects of cannabidiol (CBD) on regional cerebral blood flow.Neuropsychopharmacology. 2004 Feb;29(2):417-26. doi: 10.1038/sj.npp.1300340. Neuropsychopharmacology. 2004. PMID: 14583744 Clinical Trial.
-
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.Neuropsychopharmacology. 2011 May;36(6):1219-26. doi: 10.1038/npp.2011.6. Epub 2011 Feb 9. Neuropsychopharmacology. 2011. PMID: 21307846 Free PMC article. Clinical Trial.
-
Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.Arch Gen Psychiatry. 2009 Jan;66(1):95-105. doi: 10.1001/archgenpsychiatry.2008.519. Arch Gen Psychiatry. 2009. PMID: 19124693 Clinical Trial.
-
Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview.Epidemiol Psychiatr Sci. 2018 Aug;27(4):327-335. doi: 10.1017/S2045796018000239. Epub 2018 May 23. Epidemiol Psychiatr Sci. 2018. PMID: 29789034 Free PMC article. Review.
-
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.Braz J Psychiatry. 2012 Jun;34 Suppl 1:S104-10. doi: 10.1590/s1516-44462012000500008. Braz J Psychiatry. 2012. PMID: 22729452 Review. English, Portuguese.
Cited by
-
Exploring the Significance of Pharmaceutical Care in Mental Health: A Spotlight on Cannabis.Pharmacy (Basel). 2024 Jun 27;12(4):100. doi: 10.3390/pharmacy12040100. Pharmacy (Basel). 2024. PMID: 39051384 Free PMC article. Review.
-
"Weeding out" violence? Translational perspectives on the neuropsychobiological links between cannabis and aggression.Aggress Violent Behav. 2024 Sep-Oct;78:101948. doi: 10.1016/j.avb.2024.101948. Epub 2024 Apr 19. Aggress Violent Behav. 2024. PMID: 38828012
-
The Effect of Cannabidiol on Subjective Responses to Endurance Exercise: A Randomised Controlled Trial.Sports Med Open. 2024 May 23;10(1):61. doi: 10.1186/s40798-024-00727-3. Sports Med Open. 2024. PMID: 38782848 Free PMC article.
-
The Use of Cannabidiol in Treating Psychiatric Disorders: A Systematic Review.Psychiatry Clin Psychopharmacol. 2021 Jun 1;31(2):226-232. doi: 10.5152/pcp.2021.21743. eCollection 2021 Jun. Psychiatry Clin Psychopharmacol. 2021. PMID: 38765233 Free PMC article. Review.
-
Expectancies of the Effects of Cannabis Use in Individuals with Social Anxiety Disorder (SAD).Brain Sci. 2024 Mar 2;14(3):246. doi: 10.3390/brainsci14030246. Brain Sci. 2024. PMID: 38539634 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical